Amlan Jyoti

My first question is regarding the margin expansion that you said in FY '26, of around 150 bps. Could you please clarify how do you plan to achieve this next year?

Sir, regarding the restructuring that you're talking about, Sanofi has this been completed? Or do you see restructuring related costs for a couple of more quarters?